🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The objective of the study is to assess the bioavailability of ASP015K with...
Status
Completed
Location
Quotient Clinical Limited
Start Date
2010-09
Trial ID
NCT01430078
This is a prospective, randomized controlled trial to determine if using Fl...
Status
Completed
Location
New York University School of Medicine
Start Date
2014-03
Trial ID
NCT02701582
Treatments Being Tested
A thorough QT study of AZD3293...
Status
Completed
Location
Research Site
Start Date
2014-01
Trial ID
NCT02040987
Treatments Being Tested
Compare 0.05 μg/kg/min Norepinephrine and 0.25 μg/kg/min phenylephrine effe...
Status
Completed
Location
Xuanwu Hospital
Start Date
2019-02-20
Trial ID
NCT03833895
Treatments Being Tested
1 mist or 2 mists of the study drug will be administered to both eyes accor...
Status
Completed
Location
CODET Vision Institute
Start Date
2021-05-24
Trial ID
NCT04907474
Treatments Being Tested
The purpose of the study is to assess the short term efficacy of the Theraf...
Status
Withdrawn
Location
Multiple Locations
Start Date
2017-02-01
Trial ID
NCT02678234
Treatments Being Tested
Hypotension following spinal anesthesia for cesarean section is a serious p...
Status
Completed
Location
Multiple Locations
Start Date
2017-01
Trial ID
NCT03015857
Treatments Being Tested
This is a multicenter, 2-arm, randomized, prospective study of patients sla...
Status
Recruiting
Location
The Eye Associates - Venice
Start Date
2024-07-10
Trial ID
NCT06681688
Cystoid macular edema (CME) is a major cause of suboptimal postoperative vi...
Status
Terminated
Location
Hospital of the Brothers of Saint John of God
Start Date
2021-10-13
Trial ID
NCT05158699
A Randomised, Double-Masked, Placebo-Controlled Phase 3 Study on the Effica...
Status
Recruiting
Location
Oftex.s.r.o, oční klinika
Start Date
2024-12-30
Trial ID
NCT06514612